147 related articles for article (PubMed ID: 29692990)
1. Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2.
Fukunaga M; Nagahama K; Aoki M; Shimizu A; Hara S; Matsunaga A; Muso E; Saito T
Case Rep Nephrol Dial; 2018; 8(1):45-55. PubMed ID: 29692990
[TBL] [Abstract][Full Text] [Related]
2. A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka.
Hirashima H; Komiya T; Toriu N; Hara S; Matsunaga A; Saito T; Muso E
Clin Nephrol Case Stud; 2018; 6():45-51. PubMed ID: 30542638
[TBL] [Abstract][Full Text] [Related]
3. Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka and Homozygous Apolipoprotein E2/2 without Dyslipidemia, with Characteristic Electron-Dense Deposits.
Koshino A; Takaeda C; Matsuno T; Kitajima S; Iwata Y; Sakai N; Nagahama K; Niida Y; Saito T; Yokoyama H; Wada T
Case Rep Nephrol Dial; 2022; 12(2):96-104. PubMed ID: 35950048
[TBL] [Abstract][Full Text] [Related]
4. A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes.
Kato T; Ushiogi Y; Yokoyama H; Hara S; Matsunaga A; Muso E; Saito T
CEN Case Rep; 2019 May; 8(2):106-111. PubMed ID: 30701487
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E-related glomerular disorders.
Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
[TBL] [Abstract][Full Text] [Related]
6. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
[TBL] [Abstract][Full Text] [Related]
7. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
8. A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
Wang R; Zhao C; Chen W; Liu Z; Xie F
J Med Case Rep; 2022 Feb; 16(1):78. PubMed ID: 35193676
[TBL] [Abstract][Full Text] [Related]
9. Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature.
Kawanishi K; Sawada A; Ochi A; Moriyama T; Mitobe M; Mochizuki T; Honda K; Oda H; Nishikawa T; Nitta K
Case Rep Nephrol Urol; 2013 Jul; 3(2):128-35. PubMed ID: 24570682
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.
Takasaki S; Maeda K; Joh K; Yamakage S; Fukase S; Takahashi T; Suzuki M; Matsunaga A; Saito T
Case Rep Nephrol Dial; 2015; 5(3):204-12. PubMed ID: 26955632
[TBL] [Abstract][Full Text] [Related]
11. Unusual glomerulopathy with aggregated subepithelial microspheric particles resembling membranous nephropathy: a variant of glomerulopathy associated with podocytic infolding?
Nomura S; Inoue-Kiyohara M; Oosugi K; Ishikawa E; Obe T; Horiki T; Ito M
Clin Exp Nephrol; 2008 Dec; 12(6):513-7. PubMed ID: 18941710
[TBL] [Abstract][Full Text] [Related]
12. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
[TBL] [Abstract][Full Text] [Related]
13. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H; Yang Y; Hu Z
J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e.
Magistroni R; Bertolotti M; Furci L; Fano RA; Leonelli M; Pisciotta L; Pellegrini E; Calabresi L; Bertolini S; Calandra S
Clin Med Insights Case Rep; 2013; 6():189-96. PubMed ID: 24348079
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
Tokura T; Itano S; Kobayashi S; Kuwabara A; Fujimoto S; Horike H; Satoh M; Komai N; Tomita N; Matsunaga A; Saito T; Sasaki T; Kashihara N
J Atheroscler Thromb; 2011; 18(6):536-41. PubMed ID: 21467726
[TBL] [Abstract][Full Text] [Related]
17. Glomerular electron-dense deposits in childhood IgA nephropathy.
Yoshikawa N; Ito H; Nakahara C; Yoshiara S; Yoshiya K; Matsuo T; Hasegawa O; Hazikano H; Okada S
Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):33-43. PubMed ID: 3158115
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism and renal disease.
Oda H; Yorioka N; Ueda C; Kushihata S; Yamakido M
Kidney Int Suppl; 1999 Jul; 71():S25-7. PubMed ID: 10412731
[TBL] [Abstract][Full Text] [Related]
19. Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report.
Cautero N; Di Benedetto F; De Ruvo N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; De Blasiis MG; Rompianesi G; Iemmolo RM; Marino M; Bertolotti M; Zivieri S; Gerunda GE
Transplant Proc; 2010 May; 42(4):1349-51. PubMed ID: 20534298
[TBL] [Abstract][Full Text] [Related]
20. Overlapping IgA and membranous nephropathy.
Jennette JC; Newman WJ; Diaz-Buxo JA
Am J Clin Pathol; 1987 Jul; 88(1):74-8. PubMed ID: 3300266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
